Key statistics
On Friday, Mirum Pharmaceuticals Inc (MIRM:NMQ) closed at 39.26, -13.20% below its 52-week high of 45.23, set on Aug 28, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 39.97 |
---|---|
High | 40.36 |
Low | 39.17 |
Bid | 38.12 |
Offer | 45.96 |
Previous close | 39.61 |
Average volume | 387.64k |
---|---|
Shares outstanding | 47.71m |
Free float | 46.53m |
P/E (TTM) | -- |
Market cap | 1.87bn USD |
EPS (TTM) | -2.40 USD |
Data delayed at least 15 minutes, as of Oct 04 2024 21:00 BST.
More ▼
Press releases
- Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Mirum Pharmaceuticals to Participate in Upcoming Investor Conferences
- Mirum Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Business Update
- Mirum Pharmaceuticals to Announce Second Quarter 2024 Financial Results and Host Conference Call on August 7, 2024
- Mirum’s LIVMARLI Now Approved for PFIC in Patients 12 Months and Older
More ▼